Steven Gilman

Steven Gilman

Direktor/Vorstandsmitglied bei
Massachusetts Society for Medical Research, Inc.

Vermögen: 166 250 $ am 31.05.2026

73 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Steven C.
Gilman
is currently Director at Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Former positions include Chairman & Chief Executive Officer at ActivBiotics, Inc. from 2006 to 2007; Vice Chairman at ContraFect Corp.
from 2019 to 2023; Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc.; Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018; Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020; Director at Massachusetts Biotechnology Council; Group Director-Global Research & Development at Pfizer (St. Louis); Director at Nextcea, Inc.; Executive Director at Inhibikase Therapeutics, Inc. from 2014 to 2016; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2026; Independent Director at Vericel Corp.
from 2015 to 2025; Independent Director at SCYNEXIS, Inc. from 2015 to 2026; Scientist at Wyeth LLC; Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc. from 2000 to 2004; Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC from 2010 to 2015; Principal at Connecticut College; General Manager at Inflammation Research Association, Inc.; and Principal at Temple University School of Medicine.
Education includes undergraduate studies at Miami University and graduate and doctorate degrees from The Pennsylvania State University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
10.06.2025 152.830 ( 0,06 % ) 155 887 $ 31.05.2026
01.04.2026 14.700 ( 0,02 % ) 10 364 $ 31.05.2026

Aktive Positionen von Steven Gilman

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 07.07.2009
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Steven Gilman

UnternehmenPositionEnde
SCYNEXIS, INC. Direktor/Vorstandsmitglied 25.06.2026
AKEBIA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.04.2026
VERICEL CORPORATION Direktor/Vorstandsmitglied 30.04.2025
CONTRAFECT CORPORATION Vorstandsvorsitzender 02.04.2019
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Steven Gilman im Detail an

Ausbildung von Steven Gilman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

  1. Börse
  2. Insiders
  3. Steven Gilman